Aveo says partner Astellas will not seek EU nod for kidney cancer drug
(Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be ...
Read More »(Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be ...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Knee pain appears to decrease up to one year after "prolotherapy," a series of sugar wa...
Read More »By Trevor Stokes NEW YORK (Reuters Health) - A web-based decision-making tool that alerts heart doctors when diagnostic tests would ...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - People who had used marijuana in the past month had smaller waists and lower levels o...
Read More »By Julie Steenhuysen CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already appro...
Read More »
By Tom Miles and Stephanie Nebehay GENEVA (Reuters) - The World Health Organization (WHO) warned countries with possible cases of th...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Women in their 40s didn't cut back on mammograms during 2010, the year after a gover...
Read More »
By Susan Heavey WASHINGTON (Reuters) - U.S. schools need to boost efforts to get students moving, and make gym class as critical as ...
Read More »COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said Phase III study results had shown people t...
Read More »By Paul Sandle LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an in...
Read More »